|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Galectin Therapeutics (NASDAQ: GALT) through any online brokerage.
There are no as such competitors for Galectin Therapeutics.
The latest price target for Galectin Therapeutics (NASDAQ: GALT) was reported by HC Wainwright & Co. on 2020-08-13. The analyst firm set a price target for 12.00 expecting GALT to rise to within 12 months (a possible 428.63% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Galectin Therapeutics (NASDAQ: GALT) is $2.27 last updated Mon Apr 12 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Galectin Therapeutics.
There is no upcoming split for Galectin Therapeutics.